Skip to main content
Vaishali Pharma Limited logo

Vaishali Pharma Limited — Investor Relations & Filings

Ticker · VAISHALI ISIN · INE972X01022 LEI · 335800LHHVE3JLLKP681 National Stock Exchange of India Wholesale and retail trade
Filings indexed 428 across all filing types
Latest filing 2022-03-04 Regulatory Filings
Country IN India
Listing National Stock Exchange of India VAISHALI

About Vaishali Pharma Limited

https://www.vaishalipharma.com/

Vaishali Pharma Limited specializes in the sourcing, marketing, and distribution of a comprehensive range of healthcare products. The company’s portfolio encompasses Active Pharmaceutical Ingredients (APIs), finished formulations in various dosage forms such as tablets and injectables, and surgical supplies. It also provides veterinary products, herbal supplements, and nutraceuticals. The business model focuses on integrated supply chain management, facilitating the movement of medical products from manufacturing units to global markets. By adhering to international quality standards and leveraging an extensive distribution network, the company serves diverse therapeutic requirements. Its operations emphasize reliability in procurement and the delivery of cost-effective healthcare solutions to a global clientele across multiple regions, including Africa, Asia, and Latin America.

Recent filings

Filing Released Lang Actions
Price movement
Regulatory Filings
2022-03-04 English
Price movement
Regulatory Filings
2022-02-14 English
Copy of Newspaper Publication
Regulatory Filings Classification · 100% confidence The document contains only references to omitted pictures and no textual content or financial data. The length is very short (390 characters), and there is no indication of any report, announcement, or regulatory filing content. Given the absence of any substantive information, the document does not fit any specific report category and defaults to the fallback category for miscellaneous filings.
2022-01-22 English
Financial Result Updates
Regulatory Filings
2022-01-21 English
Financial Results Updates
Interim / Quarterly Report Classification · 95% confidence The document contains detailed financial data including quarterly and nine-month period revenue, expenses, profit before tax, tax expenses, net profit, and earnings per share. The data is unaudited for quarters and nine months, with an audited year-end figure also presented. This level of detailed financial information and period coverage is characteristic of an Interim / Quarterly Report. The document length is 3945 characters, which is relatively short but contains substantive financial data, not just an announcement or certification. Therefore, it is not a report publication announcement or regulatory filing. The presence of multiple quarters and nine-month data confirms it is a periodic interim financial report rather than a full annual report or earnings release summary. 9M 2022
2022-01-21 English
Outcome of Board Meeting
Regulatory Filings
2022-01-21 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.